Kanser Biyolojisi ve Farmakolojisi (YL) (Tezli)
Ders İçerikleri


1. Semester

Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
KBY5113 Cancer Biology and Genetics 3+0+ 5 Compulsory
Molecular and genetic mechanisms in cancer.
Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
LEE5500 Scientific Research Methods and Ethics 3+0+0 9 Compulsory

2. Semester

Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
KBY5104 Cancer Pharmacology 3+0+ 8 Compulsory
General pharmacology concepts; absorption, distribution, excretion and detoxification mechanisms; features of the autonomic nervous system, neurotransmitters, drugs used in some diseases and their mechanisms of action; Drugs used in cancer treatment, their mechanism of action and adverse effects
Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
KBY5171 Seminar 0+0+0 6 Compulsory
Making a presentation on a thesis topic

3. Semester

Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
KBY5191 Thesis Study 1 0+0+0 30 Compulsory

4. Semester

Course CodeCourse Name(T+A+L)ECTSCompulsory/Elective
KBY5192 Thesis Study 2 0+0+0 30 Compulsory


Department/Programme Elective Courses


Course CodeCourse Name(T+A+L)ECTS
KBY5005 Cell Culture Techniques 3+0+0 8
Tissue and cell culture definitions, application areas, sterile working conditions, microscopic analysis, in vitro cytotoxicity and cell death analysis.
Course CodeCourse Name(T+A+L)ECTS
KBY5009 Molecular Toxicology 3+0+0 8
Cellular mechanisms of toxicology and toxicity determination methods
Course CodeCourse Name(T+A+L)ECTS
KBY5011 Cancer Bioinformatics 3+0+0 8
The content of this course is the effective use of bioinformatics tools during cancer research and targeted drug design approaches. Another important content of the course is to convey basic information about the effective use of existing mathematical models during the experimental design phase and the interpretation of the results. The elements necessary for drug design will be emphasised with the multiple perspectives that will be gained to the students.
Course CodeCourse Name(T+A+L)ECTS
KBY5012 Tumor Heterogeneity and Drug Resistance 3+0+0 8
Molecular and genetic mechanisms of tumoral heterogeneity in cancer and cancer drug resistance that develops in parallel with it.
Course CodeCourse Name(T+A+L)ECTS
KBY5013 Current Advancements in Cancer Research 3+0+0 8
1. novel drugs 2. microbiota 3. spheroids 4. organoids 5. in ovo method 6. new hallmarks 7. new cell death modalities 8. nobel-related developments
Course CodeCourse Name(T+A+L)ECTS
KBY5014 Cancer Cell Metabolism 3+0+ 8
Changes in cellular metabolism in cancer
Course CodeCourse Name(T+A+L)ECTS
KBY5015 Anticancer Drug Discovery 3+0+0 8